Welcome to Telum Therapeutics
Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the use of Innovative Phage Lytic Proteins as antibiotics (Innobiotics).
Since the introduction of antibiotics in the ‘40s, an excessive use of them has been occurred for the treatment of animal and human infections. Over the years, this antibiotics abuse has caused the appearance and spreading of antibiotic resistance in almost all the pathogenic bacteria, some of which are even resistant to all available antibiotics.
Numerous studies place the bacteriophages and, specially, their lytic enzymes, as one of the most promising alternatives to the traditional antibiotics. For this reason, Telum Therapeutics is creating a broad bacteria and phage collection from anthropogenic and cave explorations to obtain new bacteriophages and lytic enzymes with potential antibacterial therapeutic purposes.